US Patent 11161802 L-ornithine phenyl acetate and methods of making thereof

Patent 11161802 was granted and assigned to Ocera Therapeutics on November, 2021 by the United States Patent and Trademark Office.

Overview Structured Data Issues Contributors Activity

Is a

Patent

Patent attributes

Patent Applicant

Ocera Therapeutics

Current Assignee

Ocera Therapeutics

Patent Jurisdiction

United States Patent and Trademark Office

Patent Number

111618020

Patent Inventor Names

Stephen William Watt0

Keith Anderson0

Peter Manini0

Attilia Figini0

Christine Henderson Dougan0

Jim Behling0

Date of Patent

November 2, 2021

Patent Application Number

202001310

Date Filed

January 31, 2020

Patent abstract

Disclosed herein are forms of L-ornithine phenyl acetate and methods of making the same. A crystalline form may, in some embodiments, be Forms I, II, III and V, or mixtures thereof. The crystalline forms may be formulated for treating subjects with liver disorders, such as hepatic encephalopathy. Accordingly, some embodiments include formulations and methods of administering L-ornithine phenyl acetate.